 GT-02287and GT-02329 compounds display positive effects on GCase activity and related parameters --- Study results demonstrate an increase in GCase protein levels with transport to the lysosomes and decrease of glucosylceramide and α-synuclein-p129 levels --- Comprehensive study results to be presented at Michael J. Fox Foundations upcoming Innovating from Drug Discovery to the Clinic: Novel Approaches to PD Therapeutic Development webinar --- IND-initiating study planned for Q421 